Phathom Pharmaceuticals, Inc.
PHAT • NASDAQ
Phathom Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven L. Basta, with a market cap of $1.0B.
Market Cap$1.0B
Employees112.0
CEOSteven L. Basta
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 6 daysBefore Market Open · Q1 2026
Financials
Phathom Pharmaceuticals, Inc. FAQ
Common questions about Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026 before market open. Analysts estimate revenue of $58.7M.
Phathom Pharmaceuticals, Inc. has approximately 112 employees.